Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 0R19.L
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 30.46 1.41 1.08
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -19.81 11.11 13.85
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 1.45 88.59 87.32
Cash 161.13 11.13 4.26
Capex -15.75 -0.46 -0.40
Free Cash Flow -47.34 1.32 2.50
Revenue 7.42 17.43 16.22
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 6.03 0.46 0.43
Operating Margin 51.83 0.17 0.11
ROA 84.46 < 0.005 < 0.005
ROE 88.76 0.02 0.01
ROIC 66.86 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0R19.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0R19.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0R19.L is permitted for members.